Analysis of structure-activity relationship of indol-3-yl-N-phenylcarbamic amides as potent STING inhibitors

Bioorg Med Chem. 2023 Nov 15:95:117502. doi: 10.1016/j.bmc.2023.117502. Epub 2023 Oct 14.

Abstract

A structure-activity relationship (SAR) study of stimulator of interferon gene (STING) inhibition was performed using a series of indol-3-yl-N-phenylcarbamic amides and indol-2-yl-N-phenylcarbamic amides. Among these analogs, compounds 10, 13, 15, 19, and 21 inhibited the phosphorylation of STING and interferon regulatory factor 3 (IRF3) to a greater extent than the reference compound, H-151. All five analogs showed stronger STING inhibition than H-151 on the 2',3'-cyclic GMP-AMP-induced expression of interferon regulatory factors (IRFs) in a STINGR232 knock-in THP-1 reporter cell line. The half-maximal inhibitory concentration of the most potent compound, 21, was 11.5 nM. The molecular docking analysis of compound 21 and STING combined with the SAR study suggested that the meta- and para-positions of the benzene ring of the phenylcarbamic amide moiety could be structurally modified by introducing halides or alkyl substituents.

Keywords: Cyclic AMP-GMP synthase; Interferon regulatory factor 3; STING inhibitor; Stimulator of interferon genes; cGAS-STING pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides* / pharmacology
  • Molecular Docking Simulation
  • Nucleotidyltransferases* / metabolism
  • Phosphorylation
  • Structure-Activity Relationship

Substances

  • Amides
  • Nucleotidyltransferases